#news #biotech Kahr reels in $47M to fund CD47 trial, work on TIGIT prospect

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Kahr reels in $47M to fund CD47 trial, work on TIGIT prospect .Kahr reels in $47M to fund CD47 trial, work on TIGIT prospect
ntaylor
Wed, 06/16/2021 – 06:10

from FierceBiotech: Biotech https://ift.tt/3cN8ve1